/
about us
/
technology
/
news
/
contact us
May 19, 2011
Jenken Biosciences U.S. Patent Allowed for Compounds To Treat Crohn’s Disease
April 12, 2011
Jenken Biosciences Granted Patent for Morphinans Including NCE Lead to Treat RA, MS, CD, and Organ Damages
December 30, 2010
Jenken Biosciences Amended Its Phase II trial protocol to a Two-Stage Adaptive Trial Design
March 28, 2009
Jenken Biosciences Granted Key Patent for Compounds To Treat Chronic Liver and Kidney Diseases
July 12, 2007
Jenken Biosciences Receives $142,716 for Preclinical Work
December 14, 2006
Jenken Biosciences receives FDA clearance for Phase II trial of lead compound
Copyright © 2008 Jenken Biosciences. All Rights Reserved